Physician profile
John Colleran
NPI 1265494231
$7,739.20
in general payments reported to CMS, 2019-2025
37 companies · $1,099 in 2025
The $1,099 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,854 · 2020: $705 · 2021: $1,178 · 2022: $1,041 · 2023: $842 · 2024: $1,019 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,960.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,460.80 | 2019-2025 | |
| Boston Scientific Corporation | $1,061.47 | 2019-2025 | Ekosonic, Eluvia, Synergy |
| Amgen INC. | $645.08 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $524.46 | 2019-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $453.08 | 2019-2024 | Xarelto |
| Pfizer INC. | $333.24 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $304.08 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $288.98 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $280.21 | 2021-2025 | Verquvo |
| Amarin Pharma, INC. | $278.87 | 2019-2022 | |
| Abiomed | $228.10 | 2019-2025 | |
| Shockwave Medical, INC | $192.77 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.46 | 2019-2023 | Lifevest |
| Medtronic, INC. | $149.76 | 2023 | Endurant Iis |
| Astellas Pharma US INC | $143.50 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $142.42 | 2022-2025 | Amvuttra, Onpattro |
| Abbott Laboratories | $138.86 | 2020-2024 | Jeti Peripheral Catheter, Cardiomems |
| Inari Medical, INC. | $129.47 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $125.88 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $121.62 | 2019-2025 | Camzyos, Eliquis |
| Baxter Healthcare | $91.13 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Innovation Technologies INC | $62.99 | 2025 | Irrisept |
| Bayer Healthcare Pharmaceuticals INC. | $47.42 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $46.31 | 2024 | Arcalyst |
| Gilead Sciences, INC. | $37.93 | 2019 | |
| Irhythm Technologies, INC. | $36.47 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Lexicon Pharmaceuticals, INC. | $34.25 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $31.40 | 2025 | Attruby |
| Terumo Medical Corporation | $26.45 | 2025 | Angio-Seal |
| Elutia, INC. | $25.19 | 2021 | |
| Kestra Medical Technology Services, INC. | $22.66 | 2025 | Assure Wcd |
| Medtronic Vascular, INC. | $18.32 | 2019 | |
| Cook Medical LLC | $16.36 | 2025 | Zilver Vena |
| Actelion Pharmaceuticals US, INC. | $16.12 | 2025 | Opsumit, Uptravi |
| Philips North America LLC | $15.19 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Tactile Systems Technology INC | $13.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Colleran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.